• Most Popular
  • Most Shared

Ranbaxy seeks India test on drug developed with GSK

Mon Oct 13, 2008 3:41am EDT

Stocks

   

MUMBAI, Oct 13 (Reuters) - India's Ranbaxy Laboratories Ltd (RANB.BO) said on Monday it has sought permission from Indian regulators to conduct initial-stage human clinical trials for an experimental respiratory inflammation drug it is developing with GlaxoSmithKline (GSK.L).

Under the Ranbaxy-GSK research and development collaboration, which was initiated in 2003 and expanded in 2007, Ranbaxy could receive over $100 million in potential milestone payments.

A Ranbaxy spokesman declined to comment on whether the company was getting any milestone payment for this particular move. (Reporting by Ami Shah and Bharghavi Nagaraju; Editing by John Mair)



More from Reuters

Photo

Obama blames "systemic failures" for plane attack

KANEOHE, Hawaii (Reuters) - President Barack Obama on Tuesday blamed "human and systemic failures" for allowing a botched Christmas Day attack aboard a Detroit-bound airliner and a U.S. official said the incident was linked to al Qaeda. | Video

» More Top News
A man passes by a logo of the Tokyo Stock Exchange at the bourse in Tokyo December 29, 2009. REUTERS/Yuriko Nakao

Toyko trade gets turbocharged

The "Arrowhead" gives Asia's largest -- and long derided -- bourse a viable electronic trading platform, it hopes.  Full Article 

Global Markets
REUTERS/James Saft
JAMES SAFT:

Welcome to the "Teenies"

Shrinking financial sector? Paltry investment returns? Welcome to the the next decade. Don't worry, there's some good news, too.  Commentary 

COMMENTARY